keyword
MENU ▼
Read by QxMD icon Read
search

NephroCheck

keyword
https://www.readbyqxmd.com/read/27274818/the-cell-cycle-biomarkers-promising-research-but-do-not-oversell-them
#1
REVIEW
Norbert Lameire, Jill Vanmassenhove, Wim Van Biesen, Raymond Vanholder
This review focuses on the most recent scientific and clinical information on the development and clinical applicability of the cell cycle biomarkers TIMP-2 and IGFBP-7 in the diagnosis and prognosis of patients at risk for and suffering from acute kidney injury (AKI). A number of evaluation studies have demonstrated that compared with existing biomarkers, urinary excretion of the product of both biomarkers, [TIMP-2]•[IGFBP-7], improved diagnostic performance in assessing the risk for AKI, predicting the need for renal replacement therapy, AKI-related complications and short- and long-term prognoses...
June 2016: Clinical Kidney Journal
https://www.readbyqxmd.com/read/27113693/risk-stratification-for-acute-kidney-injury-are-biomarkers-enough
#2
REVIEW
Blaithin A McMahon, Jay L Koyner
Acute kidney injury (AKI) is a common and serious complication that is associated with several adverse outcomes in hospitalized patients. AKI significantly increases the risk of mortality, need for renal replacement therapy, and intensive care admission, and it also has serious economic ramifications. Effective risk stratification to identify patients at risk for severe AKI is essential for targeting our health care and research resources to tackle this important public health issue. The overwhelming majority of research in earlier diagnosis and risk stratification of AKI over the past 10 years has focused on novel biomarker development...
May 2016: Advances in Chronic Kidney Disease
https://www.readbyqxmd.com/read/26816218/timp2%C3%A2-igfbp7-biomarker-panel-accurately-predicts-acute-kidney-injury-in-high-risk-surgical-patients
#3
MULTICENTER STUDY
Kyle J Gunnerson, Andrew D Shaw, Lakhmir S Chawla, Azra Bihorac, Ali Al-Khafaji, Kianoush Kashani, Matthew Lissauer, Jing Shi, Michael G Walker, John A Kellum
BACKGROUND: Acute kidney injury (AKI) is an important complication in surgical patients. Existing biomarkers and clinical prediction models underestimate the risk for developing AKI. We recently reported data from two trials of 728 and 408 critically ill adult patients in whom urinary TIMP2•IGFBP7 (NephroCheck, Astute Medical) was used to identify patients at risk of developing AKI. Here we report a preplanned analysis of surgical patients from both trials to assess whether urinary tissue inhibitor of metalloproteinase 2 (TIMP-2) and insulin-like growth factor-binding protein 7 (IGFBP7) accurately identify surgical patients at risk of developing AKI...
February 2016: Journal of Trauma and Acute Care Surgery
https://www.readbyqxmd.com/read/26797672/analytical-characteristics-of-a-biomarker-based-risk-assessment-test-for-acute-kidney-injury-aki
#4
Denise L Uettwiller-Geiger, Ravi Vijayendran, John A Kellum, Robert L Fitzgerald
BACKGROUND: Acute kidney injury (AKI) is associated with increased mortality, morbidity, hospital length of stay, and costs. A quantitative urine test is available to assess the risk of developing AKI by measuring the concentrations of two protein biomarkers, TIMP-2 and IGFBP-7. The NephroCheck Test combines these concentrations into an AKIRisk Score. The purpose of this study is to characterize the analytical performance characteristics of the AKIRisk Score. METHODS: Linearity and analytical sensitivity were evaluated by following Clinical Laboratory Standards Institute (CLSI) EP06-A and EP17-A, respectively...
April 1, 2016: Clinica Chimica Acta; International Journal of Clinical Chemistry
https://www.readbyqxmd.com/read/26651477/nephrocheck-data-compared-to-serum-creatinine-in-various-clinical-settings
#5
COMPARATIVE STUDY
Sahra Pajenda, Aysegül Ilhan-Mutlu, Matthias Preusser, Sebastian Roka, Wilfred Druml, Ludwig Wagner
BACKGROUND: Acute kidney injury is frequently observed at the intensive care unit, after surgery, and after toxic drug administration. A rise in serum creatinine and a fall in urine output are consequences of much earlier injury to the most sensitive part of tubular cells located at the proximal tubule. The aim of the present study was to investigate the course of two cell-cycle arrest urinary biomarkers compared to serum creatinine in four clinical settings: ischemic reperfusion injury, cardiac failure, severe acute kidney injury, and chemotherapy-induced kidney injury...
2015: BMC Nephrology
https://www.readbyqxmd.com/read/26606754/urinary-tissue-inhibitor-of-metalloproteinase-2-timp-2-%C3%A2-insulin-like-growth-factor-binding-protein-7-igfbp7-predicts-adverse-outcome-in-pediatric-acute-kidney-injury
#6
Jens H Westhoff, Burkhard Tönshoff, Sina Waldherr, Johannes Pöschl, Ulrike Teufel, Timm H Westhoff, Alexander Fichtner
BACKGROUND: The G1 cell cycle inhibitors tissue inhibitor of metalloproteinase-2 (TIMP-2) and insulin-like growth factor-binding protein 7 (IGFBP7) have been identified as promising biomarkers for the prediction of adverse outcomes including renal replacement therapy (RRT) and mortality in critically ill adult patients who develop acute kidney injury (AKI). However, the prognostic value of urinary TIMP-2 and IGFBP7 in neonatal and pediatric AKI for adverse outcome has not been investigated yet...
2015: PloS One
https://www.readbyqxmd.com/read/26522657/reference-intervals-of-urinary-acute-kidney-injury-aki-markers-igfbp7-%C3%A2-timp2-in-apparently-healthy-subjects-and-chronic-comorbid-subjects-without-aki
#7
Nandkishor S Chindarkar, Lakhmir S Chawla, Joely A Straseski, Saeed A Jortani, Denise Uettwiller-Geiger, Robert R Orr, John A Kellum, Robert L Fitzgerald
BACKGROUND: Insulin-like growth factor-binding protein 7 (IGFBP7) and tissue inhibitor of metalloproteinases-2 (TIMP-2) have demonstrated significantly improved diagnostic performance in assessing risk for acute kidney injury (AKI) compared with existing biomarkers. We present the findings of a multi-site trial to determine the reference intervals for these biomarkers in apparently healthy adults and those with stable chronic morbid conditions without AKI. METHODS: A urine specimen was collected from apparently healthy subjects (N=378) and subjects with at least one stable chronic morbidity (N=372)...
January 15, 2016: Clinica Chimica Acta; International Journal of Clinical Chemistry
https://www.readbyqxmd.com/read/25643663/biomarkers-how-precise-is-nephrocheck%C3%A2
#8
COMMENT
Jessica K Edwards
No abstract text is available yet for this article.
March 2015: Nature Reviews. Nephrology
1
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"